Businesses Continue to Violate PPE Advertising Regulations

PPE advertising
Print Friendly, PDF & Email

As the Covid-19 pandemic swept across the world, businesses rushed to satisfy the demand for personal protective equipment (“PPE”). The intention was often noble, but sometimes it was opportunistic, and some PPE advertising toed the line of legality. As a result, the U.S. Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”) began investigating businesses that made deceptive or scientifically unsupported PPE claims. Since March 6, 2020, the FDA and FTC have issued sixty-four (64) joint warning letters to businesses that may have violated federal law in their PPE advertising. Given the foregoing risk, businesses must be aware of relevant FDA and FTC regulations before bringing PPE products to market. 

What are the FDA and FTC guidelines for PPE advertising?

Compliant PPE Advertising 

The FDA and FTC’s joint warning letters were sent in reaction to PPE advertising containing claims that certain products, without approval or authorization from the FDA, mitigate, prevent, treat, diagnose, or cure COVID-19. Generally, PPE products that “are not intended for use in the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease” are not subject to FDA oversight. Certain PPE can meet the “device” definition under section 201(h) of the Federal Food, Drug, and Cosmetic Act (“FD&C”) when the PPE product is intended for medical purposes or use by health care professionals. PPE that is intended for medical purposes or use by health care professionals is subject to premarket notification requirements. Additionally, the FTC Act makes it unlawful for businesses to advertise that a product can prevent, treat, or cure a human disease unless competent and reliable scientific evidence can corroborate the veracity of such claims. 

Your education on compliance with Internet, telemarketing, and trademark law should begin with a discussion between you and an experienced attorney.
Scheduling a free consultation with Klein Moynihan Turco is a great place to start.

FDA and FTC Enforcement

The FDA and FTC have issued joint enforcement letters to PPE advertisers, but have also sent individual letters from their respective agencies when appropriate. Enforcement letters typically direct businesses to cure violations of the FD&C Act and/or the FTC Act, and require that the subject companies contact the respective agency(ies) within forty-eight (48) hours describing the specific steps that were taken to correct the applicable violations. Failing to immediately remedy such violations can result in legal action including, but not limited to, seizure, injunction and refunds to customers. In addition, businesses may also be added to a published list of businesses that have received warning letters for COVID-19 related product violations. 

It goes without saying that businesses should take appropriate measures to avoid regulatory investigation. Consulting with attorneys that are well-versed in PPE advertising before PPE products are brought to market can save time, money and reputational harm. 

If you need assistance with your PPE advertising or are being investigated by the FDA or FTC, please email us at or call us at (212) 246-0900.

The material contained herein is provided for informational purposes only and is not legal advice, nor is it a substitute for obtaining legal advice from an attorney. Each situation is unique, and you should not act or rely on any information contained herein without seeking the advice of an experienced attorney. 

Attorney Advertising

Related Blog Posts:

Sanitizer Law During a Pandemic

LendEDU to Settle Alleged FTC Marketing Violations

University of Phoenix Settles FTC Deceptive Advertising Law Allegations

David O. Klein

David O. Klein

David Klein is one of the most recognized attorneys in the telemarketing, technology, Internet marketing, sweepstakes and telecommunications fields. Skilled at counseling clients on a broad range of technology-related matters, David Klein has substantial experience in negotiating and drafting complex licensing, marketing and Internet agreements.

Schedule a Call
In The Know

Trending Topics

New York Sweepstakes Law blog- Klein Moynihan Turco

New York Sweepstakes Law: Are You Compliant?

Print Friendly, PDF & Email

In general, a lottery exists when entrants pay for the chance to win a prize. States alone reserve the right to administer lotteries. Businesses can eliminate one element of what would otherwise be an illegal lottery, in order to transform it into a legal promotional game. If the requirement to

TCPA surveys

An Ad or not an Ad: NY Weighs in on TCPA Surveys

Print Friendly, PDF & Email

Another day, another court decision that refines constitutes a Telephone Consumer Protection Act (“TCPA”) unsolicited fax advertisement. A Manhattan-based federal court recently issued a decision that removes faxed invitations to participate in a survey from the TCPA definition of advertisement. In drawing this distinction for TCPA surveys, the Court held

NY sports gambling law- Klein Moynihan Turco

Agreement Reached to Enact NY Sports Gambling Law

Print Friendly, PDF & Email

This week, Governor Andrew Cuomo and the New York State Legislature agreed to a budget deal that will bring mobile sports betting to the State through a unique NY sports gambling law.  Upon the Governor’s signature, NY sports gambling is primed to become the nation’s largest market. However, New York

UK and US Social Media Influencer Laws

UK and US Social Media Influencer Laws

Print Friendly, PDF & Email

In September of 2020, the United Kingdom’s (“UK”) Committee of Advertising Practice (“CAP”) reviewed the Instagram accounts of 122 UK-based social media influencers to determine whether content was being properly flagged as advertising in accordance with applicable social media influencer laws. This past March, the UK Advertising Standards Authority (“ASA”)

Share on facebook
Share on google
Share on twitter
Share on linkedin